Medpace Holdings, Inc.
MEDP
$419.75
$2.460.59%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.68B | 2.53B | 2.36B | 2.23B | 2.16B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.68B | 2.53B | 2.36B | 2.23B | 2.16B |
| Cost of Revenue | 752.59M | 732.13M | 717.50M | 702.70M | 688.42M |
| Gross Profit | 1.93B | 1.80B | 1.64B | 1.53B | 1.47B |
| SG&A Expenses | 187.58M | 197.56M | 198.08M | 199.21M | 194.00M |
| Depreciation & Amortization | 28.10M | 28.12M | 28.50M | 28.97M | 29.19M |
| Other Operating Expenses | 1.15B | 1.04B | 907.26M | 823.40M | 788.65M |
| Total Operating Expenses | 2.12B | 2.00B | 1.85B | 1.75B | 1.70B |
| Operating Income | 562.92M | 534.94M | 507.04M | 477.51M | 456.32M |
| Income Before Tax | 571.80M | 542.38M | 519.43M | 495.37M | 481.31M |
| Income Tax Expenses | 111.40M | 91.25M | 86.42M | 77.07M | 64.92M |
| Earnings from Continuing Operations | 460.40 | 451.12 | 433.01 | 418.30 | 416.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 460.40M | 451.12M | 433.01M | 418.30M | 416.39M |
| EBIT | 562.92M | 534.94M | 507.04M | 477.51M | 456.32M |
| EBITDA | 591.02M | 563.06M | 535.54M | 506.48M | 485.51M |
| EPS Basic | 16.24 | 15.65 | 14.66 | 13.81 | 13.51 |
| Normalized Basic EPS | 12.60 | 11.79 | 11.03 | 10.25 | 9.75 |
| EPS Diluted | 15.90 | 15.29 | 14.30 | 13.45 | 13.10 |
| Normalized Diluted EPS | 12.34 | 11.52 | 10.76 | 9.98 | 9.46 |
| Average Basic Shares Outstanding | 113.47M | 115.42M | 118.07M | 120.98M | 123.37M |
| Average Diluted Shares Outstanding | 115.89M | 118.12M | 121.03M | 124.30M | 127.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |